vs

Side-by-side financial comparison of Ametek (AME) and Intuitive Surgical (ISRG). Click either name above to swap in a different company.

Intuitive Surgical is the larger business by last-quarter revenue ($2.8B vs $2.0B, roughly 1.4× Ametek). Intuitive Surgical runs the higher net margin — 29.8% vs 19.9%, a 9.9% gap on every dollar of revenue. On growth, Intuitive Surgical posted the faster year-over-year revenue change (23.0% vs 13.4%). Over the past eight quarters, Intuitive Surgical's revenue compounded faster (17.4% CAGR vs 7.3%).

AMETEK, Inc. is an American multinational conglomerate and global designer and manufacturer of electronic instruments and electromechanical devices with headquarters in the United States and over 150 sites worldwide.

Intuitive Surgical, Inc. is an American biotechnology company that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. The company is part of the Nasdaq-100, S&P 100 and S&P 500. As of 31 December 2021, Intuitive Surgical had an installed base of 6,730 da Vinci Surgical Systems, including 4,139 in the U.S.

AME vs ISRG — Head-to-Head

Bigger by revenue
ISRG
ISRG
1.4× larger
ISRG
$2.8B
$2.0B
AME
Growing faster (revenue YoY)
ISRG
ISRG
+9.5% gap
ISRG
23.0%
13.4%
AME
Higher net margin
ISRG
ISRG
9.9% more per $
ISRG
29.8%
19.9%
AME
Faster 2-yr revenue CAGR
ISRG
ISRG
Annualised
ISRG
17.4%
7.3%
AME

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
AME
AME
ISRG
ISRG
Revenue
$2.0B
$2.8B
Net Profit
$398.6M
$826.0M
Gross Margin
36.0%
66.1%
Operating Margin
25.3%
Net Margin
19.9%
29.8%
Revenue YoY
13.4%
23.0%
Net Profit YoY
2.9%
17.4%
EPS (diluted)
$1.73
$2.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AME
AME
ISRG
ISRG
Q1 26
$2.8B
Q4 25
$2.0B
$2.9B
Q3 25
$1.9B
$2.5B
Q2 25
$1.8B
$2.4B
Q1 25
$1.7B
$2.3B
Q4 24
$1.8B
$2.4B
Q3 24
$1.7B
$2.0B
Q2 24
$1.7B
$2.0B
Net Profit
AME
AME
ISRG
ISRG
Q1 26
$826.0M
Q4 25
$398.6M
$794.8M
Q3 25
$371.4M
$704.4M
Q2 25
$358.4M
$658.4M
Q1 25
$351.8M
$698.4M
Q4 24
$387.3M
$685.7M
Q3 24
$340.2M
$565.1M
Q2 24
$337.7M
$526.9M
Gross Margin
AME
AME
ISRG
ISRG
Q1 26
66.1%
Q4 25
36.0%
66.4%
Q3 25
36.3%
66.4%
Q2 25
35.8%
66.3%
Q1 25
36.1%
64.7%
Q4 24
36.6%
68.0%
Q3 24
36.0%
67.4%
Q2 24
36.0%
68.3%
Operating Margin
AME
AME
ISRG
ISRG
Q1 26
Q4 25
25.3%
30.2%
Q3 25
25.8%
30.3%
Q2 25
26.0%
30.5%
Q1 25
26.3%
25.7%
Q4 24
26.6%
30.4%
Q3 24
26.1%
28.3%
Q2 24
25.8%
28.2%
Net Margin
AME
AME
ISRG
ISRG
Q1 26
29.8%
Q4 25
19.9%
27.7%
Q3 25
19.6%
28.1%
Q2 25
20.2%
27.0%
Q1 25
20.3%
31.0%
Q4 24
22.0%
28.4%
Q3 24
19.9%
27.7%
Q2 24
19.5%
26.2%
EPS (diluted)
AME
AME
ISRG
ISRG
Q1 26
$2.28
Q4 25
$1.73
$2.19
Q3 25
$1.60
$1.95
Q2 25
$1.55
$1.81
Q1 25
$1.52
$1.92
Q4 24
$1.67
$1.89
Q3 24
$1.47
$1.56
Q2 24
$1.45
$1.46

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AME
AME
ISRG
ISRG
Cash + ST InvestmentsLiquidity on hand
$458.0M
Total DebtLower is stronger
$2.3B
Stockholders' EquityBook value
$10.6B
$17.6B
Total Assets
$16.1B
$20.1B
Debt / EquityLower = less leverage
0.21×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AME
AME
ISRG
ISRG
Q1 26
Q4 25
$458.0M
$5.9B
Q3 25
$439.2M
$4.9B
Q2 25
$619.7M
$5.3B
Q1 25
$399.0M
$4.5B
Q4 24
$374.0M
$4.0B
Q3 24
$396.3M
$4.2B
Q2 24
$396.6M
$4.8B
Total Debt
AME
AME
ISRG
ISRG
Q1 26
Q4 25
$2.3B
Q3 25
Q2 25
Q1 25
Q4 24
$2.1B
Q3 24
Q2 24
Stockholders' Equity
AME
AME
ISRG
ISRG
Q1 26
$17.6B
Q4 25
$10.6B
$17.8B
Q3 25
$10.5B
$16.9B
Q2 25
$10.4B
$17.8B
Q1 25
$10.0B
$17.1B
Q4 24
$9.7B
$16.4B
Q3 24
$9.6B
$15.6B
Q2 24
$9.3B
$14.7B
Total Assets
AME
AME
ISRG
ISRG
Q1 26
$20.1B
Q4 25
$16.1B
$20.5B
Q3 25
$16.2B
$19.4B
Q2 25
$15.3B
$20.2B
Q1 25
$14.9B
$19.2B
Q4 24
$14.6B
$18.7B
Q3 24
$14.8B
$17.7B
Q2 24
$14.8B
$16.6B
Debt / Equity
AME
AME
ISRG
ISRG
Q1 26
Q4 25
0.21×
Q3 25
Q2 25
Q1 25
Q4 24
0.22×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AME
AME
ISRG
ISRG
Operating Cash FlowLast quarter
$584.3M
Free Cash FlowOCF − Capex
$527.3M
FCF MarginFCF / Revenue
26.4%
Capex IntensityCapex / Revenue
2.9%
Cash ConversionOCF / Net Profit
1.47×
TTM Free Cash FlowTrailing 4 quarters
$1.7B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AME
AME
ISRG
ISRG
Q1 26
Q4 25
$584.3M
$892.5M
Q3 25
$440.9M
$841.0M
Q2 25
$359.1M
$715.4M
Q1 25
$417.5M
$581.6M
Q4 24
$550.0M
$822.6M
Q3 24
$487.2M
$706.5M
Q2 24
$381.4M
$620.5M
Free Cash Flow
AME
AME
ISRG
ISRG
Q1 26
Q4 25
$527.3M
$730.0M
Q3 25
$420.0M
$735.6M
Q2 25
$329.8M
$560.1M
Q1 25
$394.5M
$465.0M
Q4 24
$498.3M
$510.6M
Q3 24
$460.9M
$458.6M
Q2 24
$360.0M
$311.1M
FCF Margin
AME
AME
ISRG
ISRG
Q1 26
Q4 25
26.4%
25.5%
Q3 25
22.2%
29.4%
Q2 25
18.5%
23.0%
Q1 25
22.8%
20.6%
Q4 24
28.3%
21.2%
Q3 24
27.0%
22.5%
Q2 24
20.8%
15.5%
Capex Intensity
AME
AME
ISRG
ISRG
Q1 26
Q4 25
2.9%
5.7%
Q3 25
1.1%
4.2%
Q2 25
1.6%
6.4%
Q1 25
1.3%
5.2%
Q4 24
2.9%
12.9%
Q3 24
1.5%
12.2%
Q2 24
1.2%
15.4%
Cash Conversion
AME
AME
ISRG
ISRG
Q1 26
Q4 25
1.47×
1.12×
Q3 25
1.19×
1.19×
Q2 25
1.00×
1.09×
Q1 25
1.19×
0.83×
Q4 24
1.42×
1.20×
Q3 24
1.43×
1.25×
Q2 24
1.13×
1.18×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AME
AME

Transferred At Point In Time$1.1B54%
Electronic Instruments Group$620.1M31%
Transferred Over Time$294.6M15%

ISRG
ISRG

Instruments and accessories$1.7B61%
Systems$650.7M23%
Services$433.7M16%

Related Comparisons